SELECT * FROM `stock_list` where symbol='B3BN' AND exchange = 'STU' limit 0,1
SELECT * FROM `stock_list` where symbol='B3BN' AND exchange = 'STU' limit 0,1
SELECT * FROM `stock_list` WHERE `symbol` = "B3BN" and stock_list.exchange IN (SELECT exchange FROM gurufocu_main.stock_list_exchanges where country='USA' and active=1) limit 0,1 CVR Medical (STU:B3BN) EV-to-EBIT
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CVR Medical Corp (STU:B3BN) » Definitions » EV-to-EBIT

CVR Medical (STU:B3BN) EV-to-EBIT : -1.34 (As of May. 01, 2024)


View and export this data going back to 2016. Start your Free Trial

What is CVR Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CVR Medical's Enterprise Value is €2.29 Mil. CVR Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was €-1.72 Mil. Therefore, CVR Medical's EV-to-EBIT for today is -1.34.

The historical rank and industry rank for CVR Medical's EV-to-EBIT or its related term are showing as below:

STU:B3BN's EV-to-EBIT is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 20.05
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. CVR Medical's Enterprise Value for the quarter that ended in Sep. 2022 was €2.32 Mil. CVR Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was €-1.72 Mil. CVR Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -73.82%.


CVR Medical EV-to-EBIT Historical Data

The historical data trend for CVR Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CVR Medical EV-to-EBIT Chart

CVR Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.65 -2.23 -3.08 -26.17 -2.04

CVR Medical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.88 -2.04 -1.83 -1.10 -1.14

Competitive Comparison of CVR Medical's EV-to-EBIT

For the Medical Devices subindustry, CVR Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVR Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CVR Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CVR Medical's EV-to-EBIT falls into.



CVR Medical EV-to-EBIT Calculation

CVR Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2.293/-1.716
=-1.34

CVR Medical's current Enterprise Value is €2.29 Mil.
CVR Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CVR Medical  (STU:B3BN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

CVR Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2022 ) =EBIT / Enterprise Value (Q: Sep. 2022 )
=-1.716/2.3246455
=-73.82 %

CVR Medical's Enterprise Value for the quarter that ended in Sep. 2022 was €2.32 Mil.
CVR Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CVR Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of CVR Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


CVR Medical (STU:B3BN) Business Description

Traded in Other Exchanges
N/A
Address
221 West Esplanade, c/o Suite 409, North Vancouver, Vancouver, BC, CAN, V7M 3J3
CVR Medical Corp is a medical device company. The company commercializing its Carotid Stenotic Scan (CSS), a patented, diagnostic tool that utilizes subsonic, infrasonic, and low-frequency sound wave analysis technology to detect and measure carotid arterial stenosis.

CVR Medical (STU:B3BN) Headlines

No Headlines